Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)

NCT06621459 · clinicaltrials.gov ↗

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Brest Cancer
Abemaciclib
Adjuvant Therapy
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms

Sponsor

University Hospital, Brest